Stefan H. Hohnloser

Also affiliated with Goethe-Institute United Kingdom

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 8 papers. Top paper: “Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation”.

Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation

Journal of the American College of Cardiology(2024)10.1016/j.jacc.2024.05.002

N/A

1.8DataRank · unranked

72 citations

Christopher B. Granger, Daniel Wojdyla, William F. McIntyre, Marco Alings, Thenmozhi Mani +23 more

Apixaban versus Warfarin in Patients with Atrial Fibrillation

New England Journal of Medicine(2011)10.1056/nejmoa1107039

N/A

1.4DataRank · unranked

8849 citations

John H. Alexander, John J.V. McMurray, Renato D. Lopes, Elaine M. Hylek, Michael Hanna +37 more

2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS

European Heart Journal(2016)10.1093/eurheartj/ehw210

N/A

1.3DataRank · unranked

6424 citations

Stefano Benussi, Dipak Kotecha, Anders Ahlsson, Dan Atar, Barbara Casadei +54 more

Inhibition of the KCa2 potassium channel in atrial fibrillation: a randomized phase 2 trial

Nature Medicine(2023)10.1038/s41591-023-02679-9

N/A

1.1DataRank · unranked

37 citations

János Tomcsányi, Birgitte Vestbjerg, Morten Grunnet, Ulrik S. Sørensen, Jonas Goldin Diness +6 more

Periprocedural anticoagulation in the uninterrupted edoxaban vs. vitamin K antagonists for ablation of atrial fibrillation (ELIMINATE-AF) trial

EP Europace(2020)10.1093/europace/euaa199

N/A

0.359DataRank · unranked

7 citations

A. John Camm, Riccardo Cappato, Hans‐Christoph Diener, Hein Heidbüchel, Lluı́s Mont +7 more

Risk Stratification for SCD

Sudden Cardiac Death(2005)10.1002/9781444312881.ch4

N/A

0.165DataRank · unranked

2 citations

Wojciech Zareba, Stefan H. Hohnloser

Outcomes of patients with atrial fibrillation and ischemic stroke while on oral anticoagulation

European Heart Journal(2023)10.1093/eurheartj/ehad200

N/A

0DataRank · unranked

54 citations

Stefan H. Hohnloser, John W. Eikelboom, Anthony Carnicelli, Robert P. Giugliano, Christopher B. Granger +10 more

Individual Patient Data from the Pivotal Randomized Controlled Trials of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation (COMBINE AF): Design and Rationale

American Heart Journal(2020)10.1016/j.ahj.2020.12.002

N/A

0DataRank · unranked

32 citations

Hwanhee Hong, Robert P. Giugliano, Stuart J. Connolly, John W. Eikelboom, Manesh R. Patel +12 more